Journal of Hepatology
(J HEPATOL ) 《肝脏病学杂志 》
2015年影响因子
10.59
期刊介绍
"The Journal of Hepatology is the official journal of the European Association for the Study of the Liver (EASL). The journal publishes original papers, reviews, case reports and letters to the Editor concerned with clinical and basic research in the field of hepatology. The Journal is published in English.
More"
展开
推荐阅读
- 2013-03-18•呼气挥发性有机物分析可准确检测NASH
- 2013-08-09•对阿德福韦反应不足的患者接受恩曲他滨联合替诺福韦联合治疗或者诺福韦单药治疗的HBV准种进化相似
- 2011-09-23•胃底静脉曲张破裂出血的一级预防中,氰基丙烯酸酯注射和β-阻断剂的比较:一项随机对照试验
- 2011-08-25•基因4型丙型肝炎病毒感染的治疗:一个国际专家组的建议
- 2009-06-22•比较生长抑素基础上添加急诊内镜下结扎与添加急诊内镜下硬化疗法治疗急性静脉曲张出血的随机对照试验
- 2009-06-22•比较动态个体化方案与标准方案治疗慢性丙型肝炎的国际、多中心、随机、对照研究
- 2009-06-22•体重和生活方式改变对非酒精性脂肪性肝病的影响
- 2014-01-16•乙型肝炎病毒相关性失代偿期肝硬化:抗病毒治疗的益处
- 2013-07-17•肝硬化患者中已确立和新一代抗凝血药物—可能与注意事项
- 2013-07-17•肺禁忌症,适应症和肝移植MELD例外:当代观点和展望
- 2013-07-17•丙肝治疗中的NS5A抑制剂
- 2013-07-17•肝脏形状细胞至静息表型的逆转:神话到现实?
- 2013-07-17•再思考肝细胞癌分子治疗的未来发展:自底向上方法
- 2016-07-08•针对肝细胞TRAF1-ASK1信号的靶向治疗可改善炎症、胰岛素抵抗及肝脏脂肪变性
- 2016-07-08•长链非编码RNA-DILC可通过IL-6/STAT3轴调节肝癌干细胞
- 2016-07-08•人类肝脏移植供体的PD-L1及移植受体的PD-1相互作用可反向调节排斥活性
- 2016-01-13•Slit2-Robo1信号的激活促进肝纤维化
- 2016-01-12•雌激素上调miR-125b预防雌性小鼠的非酒精性脂肪肝
- 2015-09-20•非酒精性脂肪性肝病和高尿酸血症的黄嘌呤氧化酶:一石二鸟
目录导读
Published 2013年8月,Volume 59,Issue 2
最新一期
Article Title | Author(s) | Pages | ||
---|---|---|---|---|
Editorial Board
|
iii | |||
Translational Research in Chronic Viral Hepatitis: EASL Monothematic Conference, Lyon 2013
|
iv | |||
Hot Topics in Hepatology, EASL Masterclass, Bordeaux 2013
|
v | |||
Course 21: General Hepatology, EASL Clinical School of Hepatology, Bern 2013
|
vi | |||
Course 9: Epithelial Mesenchymal Interactions In Liver Development, Diseases and Cancer. EASL Basic School of Hepatology, Milan 2014
|
vii | |||
Contents
|
ix-xi | |||
Focus | ||||
Article Title | Author(s) | Pages | ||
Focus
|
Daniel Shouval | 201-202 | ||
Editorial | ||||
Article Title | Author(s) | Pages | ||
Care coordination for patients with cirrhosis: A “win-win” solution for patients, caregivers, providers, and healthcare expenditures
|
Phillip S. Ge, Bruce A. Runyon | 203-204 | ||
Research Articles | ||||
Viral Hepatitis | ||||
Article Title | Author(s) | Pages | ||
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C
|
Norihiro Furusyo, Eiichi Ogawa, Makoto Nakamuta, Eiji Kajiwara, et al. | 205-212 | ||
Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
|
Jürgen K. Rockstroh, Lars Peters, Daniel Grint, Vincent Soriano, et al. | 213-220 | ||
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection
|
Alessandra Mangia, Rosanna Santoro, Massimiliano Copetti, Marco Massari, et al. | 221-228 | ||
Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C
|
Bettina Langhans, Benjamin Krämer, Marcell Louis, Hans Dieter Nischalke,et al. | 229-235 | ||
Cirrhosis | ||||
Article Title | Author(s) | Pages | ||
The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values
|
Ralf Lichtinghagen, Daniel Pietsch, Heike Bantel, Michael P. Manns, et al. | 236-242 | ||
Increased risk of cognitive impairment in cirrhotic patients with bacterial infections
|
Manuela Merli, Cristina Lucidi, Ilaria Pentassuglio, Valerio Giannelli,et al. | 243-250 | ||
The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response
|
Roberta D’Ambrosio, Alessio Aghemo, Mirella Fraquelli, Maria Grazia Rumi, et al. | 251-256 | ||
How to improve care in outpatients with cirrhosis and ascites: A new model of care coordination by consultant hepatologists
|
Filippo Morando, Giulio Maresio, Salvatore Piano, Silvano Fasolato,et al. | 257-264 | ||
Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis
|
Armando Tripodi, Massimo Primignani, Laura Lemma, Veena Chantarangkul,et al. | 265-270 | ||
Transplantation | ||||
Article Title | Author(s) | Pages | ||
Imaging of hepatitis C virus infection in liver grafts after liver transplantation
|
Laura Mensa, Sofía Pérez-del-Pulgar, Gonzalo Crespo, George Koutsoudakis, et al. | 271-278 | ||
How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?
|
Gerd Otto, Marcus Schuchmann, Maria Hoppe-Lotichius, Michael Heise, et al. | 279-284 | ||
Liver Failure and Growth | ||||
Article Title | Author(s) | Pages | ||
Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice
|
Ivan Quétier, Nicolas Brezillon, Marion Duriez, Hélène Massinet,et al. | 285-291 | ||
Cancer | ||||
Article Title | Author(s) | Pages | ||
Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression
|
Yoshifumi Morita, Takanori Sakaguchi, Koji Ikegami, Naoko Goto-Inoue, et al. | 292-299 | ||
Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
|
Alessandro Cucchetti, Fabio Piscaglia, Matteo Cescon, Antonio Colecchia, et al. | 300-307 | ||
Molecular and Cell Biology | ||||
Article Title | Author(s) | Pages | ||
Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: Role of autophagy
|
Xihui Xu, Lindsay K. Hueckstaedt, Jun Ren | 308-317 | ||
Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model
|
S.M. Robinson, J. Mann, A. Vasilaki, J. Mathers, et al. | 318-326 | ||
Cholestasis and Autoimmune Diseases | ||||
Article Title | Author(s) | Pages | ||
A validated clinical tool for the prediction of varices in PBC: The Newcastle Varices in PBC Score
|
Imran Patanwala, Peter McMeekin, Ruth Walters, George Mells, et al. | 327-335 | ||
Genetic and Metabolic Diseases | ||||
Article Title | Author(s) | Pages | ||
Arylacetamide deacetylase: A novel host factor with important roles in the lipolysis of cellular triacylglycerol stores, VLDL assembly and HCV production
|
Mahra Nourbakhsh, Donna N. Douglas, Christopher Hao Pu, Jamie T. Lewis, et al. | 336-343 | ||
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease
|
Eric Trépo, Romy Ouziel, Pierre Pradat, Yukihide Momozawa, et al. | 344-350 | ||
Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses
|
Chan-Won Kim, Kyung Eun Yun, Hyun-Suk Jung, Yoosoo Chang,et al. | 351-357 | ||
Reviews | ||||
Article Title | Author(s) | Pages | ||
Established and new-generation antithrombotic drugs in patients with cirrhosis – Possibilities and caveats
|
Ton Lisman, Pieter W. Kamphuisen, Patrick G. Northup, Robert J. Porte | 358-366 | ||
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: A contemporary view and look forward
|
Michael J. Krowka, Russell H. Wiesner, Julie K. Heimbach | 367-374 | ||
NS5A inhibitors in the treatment of hepatitis C
|
Jean-Michel Pawlotsky | 375-382 | ||
Special Sections | ||||
International Hepatology | ||||
Article Title | Author(s) | Pages | ||
Reversion of hepatic stellate cell to a quiescent phenotype: From myth to reality?
|
Ariane Mallat, Sophie Lotersztajn | 383-386 | ||
Hepatology Snapshots | ||||
Article Title | Author(s) | Pages | ||
Alcohol and toxicity
|
Ivan Rusyn, Ramon Bataller | 387-388 | ||
Autophagy in the liver
|
Patrice Codogno, Alfred J. Meijer | 389-391 | ||
Clinical Application of Basic Science | ||||
Article Title | Author(s) | Pages | ||
Rethinking future development of molecular therapies in hepatocellular carcinoma: A bottom-up approach
|
Augusto Villanueva | 392-395 | ||
Letters to the Editor | ||||
Article Title | Author(s) | Pages | ||
SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting
|
Daniel F. Wallace | 396-397 | ||
Reply to: “SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting”
|
Matthaios Speletas, Anna Kioumi, Anastasios E. Germenis | 397 | ||
The autophagic response to alcohol toxicity: The missing layer
|
Nabil Eid, Yuko Ito, Yoshinori Otsuki | 398 | ||
Reply to: “The autophagic response to alcohol toxicity: The missing layer”
|
Ivan Rusyn, Ramon Bataller | 399-400 | ||
Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention
|
Ka Wang Cheung, Mimi Tin Yan Seto, Chin Peng Lee | 400 | ||
Reply to: Mother-to-infant transmission of hepatitis B virus infection: Significance of maternal viral load and strategies for intervention
|
Wan-Hsin Wen, Mei-Hwei Chang, Huey-Ling Chen | 401 | ||
Erratum | ||||
Article Title | Author(s) | Pages | ||
Erratum to: “Digital image analysis of collagen assessment of progression of fibrosis in recurrent HCV after liver transplantation” [J Hepatol 2013;58:962–968]
|
Pinelopi Manousou, Andrew K. Burroughs, Emmanuel Tsochatzis, Graziela Isgro, et al. | 402 |
发表评论网友评论(0)